These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21142899)

  • 1. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
    Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
    Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
    Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of nondermatophyte molds isolated from onycomycosis to antifungal drugs.
    Trovato L; Rapisarda MF; Greco AM; Galata F; Oliveri S
    J Chemother; 2009 Aug; 21(4):403-7. PubMed ID: 19622458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.
    Santos DA; Hamdan JS
    Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis.
    Toukabri N; Corpologno S; Bougnoux ME; El Euch D; Sadfi-Zouaoui N; Simonetti G
    Mycoses; 2018 Feb; 61(2):79-87. PubMed ID: 28940733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low
    Abastabar M; Haghani I; Shokohi T; Hedayati MT; Aghili SR; Jedi A; Dadashi S; Shabanzadeh S; Hosseini T; Aslani N; Meis JF; Badali H
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomycosis: clinical, mycological and in vitro susceptibility testing of isolates of Trichophyton rubrum.
    Azambuja CV; Pimmel LA; Klafke GB; Xavier MO
    An Bras Dermatol; 2014; 89(4):581-6. PubMed ID: 25054744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
    Tsang CC; Tang JYM; Chan KF; Lee CY; Chan JFW; Ngan AHY; Cheung M; Lau ECL; Li X; Ng RHY; Lai CKC; Fung KSC; Lau SKP; Woo PCY
    Emerg Microbes Infect; 2019; 8(1):531-541. PubMed ID: 30938262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mycological and Molecular Epidemiologic Study on Onychomycosis and Determination
    Halvaee S; Daie-Ghazvini R; Hashemi SJ; Khodavaisy S; Rahimi-Foroushani A; Bakhshi H; Rafat Z; Ardi P; Abastabar M; Zareei M; Borjian-Boroujeni Z; Kamali Sarvestani H
    Front Cell Infect Microbiol; 2021; 11():693522. PubMed ID: 34336717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
    Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility.
    Carrillo-Muñoz AJ; Fernández-Torres B; Cárdenes DC; Guarro J
    Chemotherapy; 2003 Sep; 49(5):248-51. PubMed ID: 14504436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal susceptibility testing method for resource constrained laboratories.
    Khan S; Singhal S; Mathur T; Upadhyay DJ; Rattan A
    Indian J Med Microbiol; 2006 Jul; 24(3):171-6. PubMed ID: 16912435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of butenafine against ocular pathogenic filamentous fungi in vitro].
    Xu Y; Pang GR; Zhao DQ; Gao CW; Zhou LT; Sun ST; Wang BL; Chen ZJ
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):38-42. PubMed ID: 20388321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals.
    Ghannoum MA; Arthington-Skaggs B; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rennie R; Rinaldi MG; Walsh TJ
    J Clin Microbiol; 2006 Dec; 44(12):4353-6. PubMed ID: 17050812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.